Fibrosol® Non-Adhesive is made of 100% CMC fibers, that are carded to form a nonwoven, reinforced with yarns used to stitch bond the product for support.

Fibrosol® Extra Non-Adhesive is made of 100% CMC fibers, that are carded with yarn forming a double layered nonwoven stitched together to give high strength and more integrity during dressing removal.

• Partial thickness (second degree) burns;
• Diabetic foot ulcers, leg ulcers (venous stasis ulcers, arterial ulcers and leg ulcers of mixed etiology), Diabetic ulcers and pressure ulcers/sores (partial & full thickness);
• Wounds as an effective barrier to bacterial penetration of the dressing as this may help reduce infection;
• Surgical wounds left to heal by secondary intention such as dehisced Surgical incisions;
• Surgical wounds that heal by primary intention such as derma¬tological, post-operative, donor sites and surgical incisions (e.g. orthopedic and vascular);
• Traumatic wounds;
• Wounds that are prone to bleeding, such as wounds that have been mechanically or surgically debrided and donor sites;
• Oncology wounds with exudate, such as fungoides-cutaneous tumors, fungating carcinoma, cutaneous metastasis, Kaposi’s sarcoma, and angiosarcoma;
• Management of painful wounds.

• Fibrosol® Non-Adherent wound pad shall not be used on individuals who are sensitive to or who have had an allergic reaction to the dressings or any of its components (e.g. sodium carboxymethylcellulose).
• The dressings are not intended for use as a surgical sponge or in third degree burns.
• The dressings are not intended for use within internal body cavities or within closed wounds.

• Sterility is guaranteed unless pouch is damaged or opened prior to use. Discard any unused portion of the product after dressing the wound. If the immediate product packaging is damaged, do not use.
• This device is for single-use only and shall not be re-used. Re-use may lead to increased risk of infection or cross contamination. Physical properties of the device may no longer be optimal for intended use.
• This wound dressing shall not be used with other wound care products without first consulting a healthcare professional.
• The wound shall be inspected during dressing changes and appropriate treatment given if there are: a) signs of infection (increased pain, increased redness, wound drainage), b) bleeding, c) a change in wound color and/or odor, d) irritation (increased redness and/or inflammation), e) maceration (skin whitening), f) hypergranulation (excessive tissue formation), g) sensitivity (allergic reaction), h) no signs of healing.
• The Dressing is not compatible with oil-based products, such as petrolatum.
• In partial thickness (second degree) burns, consider alternate (surgical) procedures if the wound has not re-epithelialized after 14 days.
• The use of Fibrosol® Non-Adherent wound pad has not been studied in wounds due to herpes simplex or impetigo.
• The dressing may be used on infected wounds only under the care of a healthcare professional.
• In addition, for leg ulcers, pressure ulcers, diabetic ulcers, second degree burns, donor sites, surgical or traumatic wounds left to heal by primary or secondary intention:

-Treatment of the wound types listed above shall only be under the supervision of a healthcare professional.

-Appropriate supportive measures shall be taken where indicated (e.g. use of graduated compression bandaging in the management of venous leg ulcers or pressure relief measures in the management of pressure ulcers, systemic antibiotics and frequent monitoring in the treatment of wound infection, control of blood glucose for diabetic ulcers, etc.).

-Colonization of chronic wounds is common and is not a contraindication to the use of

the dressing. The dressing may be used on Infected wounds under medical supervision together with appropriate therapy and frequent monitoring of the wound.

-The control of blood glucose, as well as appropriate supportive measures, shall be provided with diabetic foot ulcers.

• The use of dressings as part of a prophylactic therapy does not preclude the need to continue to develop and follow a comprehensive protocol of care to protect against skin breakdown i.e support surfaces, positioning, nutrition, hydration, skin care and mobility.
• In order to minimize the risk of potential infection hazard or environmental pollution, disposing the medical device should follow disposal procedures according to applicable local laws.

Also, for Fibrosol® Non-Adherent wound pad:

• In the management of partial thickness burns and donor sites adherence to the wound bed of the Fibrosol® Non-Adherent wound pad is a desired characteristic.
• If you have difficulty removing the dressing, it shall be soaked with sterile water or sterile saline until it removes easily.

The Fibrosol® Non-Adherent wound pad and Fibrosol® Foam Dressings absorb fluid directly into the gelling fibers (sodium carboxymethylcellulose). Exudate is preferentially absorbed into the dressing immediately over the wound, keeping fluid away from the peripheral skin so reducing the risk of maceration. The fluid held directly within the fiber structure is in effect ‘locked’ in the dressing and there is little release of fluid back to the skin/wound surface. The risk of wound edge and surrounding tissue maceration is therefore reduced. As the fibers absorb exudate they swell and gel conforming to the wound surface, eliminating dead space and maintaining an optimal moist wound healing environment. In addition, the gelling action is able to immobilise bacteria, trapping it within its fibers.